Victoria Vakiener - 02 May 2022 Form 3 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Victoria Vakiener
Issuer symbol
ARWR
Transactions as of
02 May 2022
Net transactions value
$0
Form type
3
Filing time
05 May 2022, 18:15:37 UTC
Previous filing
25 Jun 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARWR Common Stock 17,181 02 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 17,181 shares underlying restricted stock units, which will vest over three years.